Cargando…
Comparative Genomic Assessment of Novel Broad-Spectrum Targets for Antibacterial Drugs
Single and multiple resistance to antibacterial drugs currently in use is spreading, since they act against only a very small number of molecular targets; finding novel targets for anti-infectives is therefore of great importance. All protein sequences from three pathogens (Staphylococcus aureus, My...
Autores principales: | White, Thomas A., Kell, Douglas B. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2004
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2447455/ https://www.ncbi.nlm.nih.gov/pubmed/18629165 http://dx.doi.org/10.1002/cfg.411 |
Ejemplares similares
-
Molecular Topology for the Discovery of New Broad-Spectrum Antibacterial Drugs
por: Bueso-Bordils, Jose I., et al.
Publicado: (2020) -
HAZ, a novel peptide with broad-spectrum antibacterial activity
por: Alsaggar, Mohammad, et al.
Publicado: (2022) -
Lipophosphonoxins—A Novel Group of Broad Spectrum Antibacterial Compounds
por: Šebek, Viktor, et al.
Publicado: (2023) -
Evaluation of robenidine analog NCL195 as a novel broad-spectrum antibacterial agent
por: Ogunniyi, Abiodun D., et al.
Publicado: (2017) -
Light-activated molecular machines are fast-acting broad-spectrum antibacterials that target the membrane
por: Santos, Ana L., et al.
Publicado: (2022)